Which of the following statements about pegfilgrastim is true?: (A) It decrease the risk of neutropenia in patients on anti cancer therapy, (B) It is a sho acting drug, (C) It can be given orally, (D) It is recombinant GM CSF
Answer is A. PEGFILGRASTIM:- Long acting granulocyte colony stimulating factor (GCSF). It is used along with anticancer drug to decrease neutropenia. Commonly given by SC route. Drug ending with GRASTIM are granulocytes stimulator. Drug ending with GRAMOSTIM are granulocyte monocyte stimulator. Eg:- SARGRAMOSTIM.